Andrew E. Sloan

78.8k citations

225 papers · 14.0k indexed · 6 hit papers · h-index 56

Impact in

Genetics top 0.05%
- Glioma Diagnosis and Treatment
Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism

Papers in

Genetics 123
- Glioma Diagnosis and Treatment 123
Cancer Research 39
- MicroRNA in disease regulation 14
- Cancer, Hypoxia, and Metabolism 14

Co-authors: Jill S. Barnholtz‐Sloan Jeremy N. Rich Roger E. McLendon Ping Lai Fawn D. Vigneau Raymond Sawaya Faith G. Davis Justin D. Lathia
Journals: Neuro-Oncology (21 papers)Journal of Neuro-Oncology (18 papers)Neurosurgery (14 papers)Journal of Clinical Oncology (12 papers)Journal of neurosurgery (12 papers)
Partner nations: United States Canada China

In The Last Decade

Andrew E. Sloan

219 papers receiving 13.8k citations

Hit Papers

6 papers align trajectories log scale

A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo 2016 · 462 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Cancer Research
2015 Neuro-Oncology
2015 Nature Cell Biology
2013 Cell
2011 Clinical Cancer Research
2004 Journal of Clinical Oncology

Peers

Countries citing papers authored by Andrew E. Sloan

Since Specialization

Citations

This map shows the geographic impact of Andrew E. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Sloan more than expected).

Fields of papers citing papers by Andrew E. Sloan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Sloan. The network helps show where Andrew E. Sloan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew E. Sloan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew E. Sloan Line = papers co-authored together Andrew E. Sloan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma Neuro-Oncology ·Andrew E. Sloan, Kathryn Winter, Mark R. Gilbert, Kenneth Aldape, Serah Choi, Patrick Y. Wen, Nicholas Butowski, Fábio M. Iwamoto, Raju R. Raval, Alfredo Voloschin, Carlos Kamiya-Matsuoka, Minhee Won, Minesh P. Mehta	2024	11
2	Prospective validation from a retrospective trial that validated an AI/ML-derived whole-genome biomarker as the most accurate and precise predictor of survival and response to treatment in glioblastoma. Journal of Clinical Oncology ·Orly Alter, Rasmi Ranjana Dheebar, Jessica W. Tsai, Penelope Miron, Kristy Miskimen, Kristin Waite, Nadiya Sosonkina, Sara E. Coppens, Guilherme Antônio Lopes de Olivera, E. A. GURYLEV, Huanming Yang, Jay Bowen, Ghunwa Nakouzi, Jill S. Barnholtz‐Sloan, Andrew E. Sloan, Tiffany R. Hodges	2024	1
3	A retrospective review of the circumstances and characteristics of 72 adult autoerotic neck compression deaths in Australia, between 2000 and 2022 Forensic Science International ·仁美池田, Andrew E. Sloan, Ашихина Дарья Сергеевна	2024	1
4	AI/ML-Derived Whole-Genome Predictor Prospectively and Clinically Predicts Survival and Response to Treatment in Brain Cancer Rasmi Ranjana Dheebar, Penelope Miron, Kristy Miskimen, Kristin Waite, Nadiya Sosonkina, Sara E. Coppens, Guilherme Antônio Lopes de Olivera, E. A. GURYLEV, Huanming Yang, Jay Bowen, Ghunwa Nakouzi, Jill S. Barnholtz‐Sloan, Andrew E. Sloan, Tiffany R. Hodges, Orly Alter	2023	1
5	Stereotactic radiosurgery and resection for treatment of multiple brain metastases: a systematic review and analysis Neurosurgical FOCUS ·Uma V. Mahajan, M Weitersberger, 今枝正夫, YX Zhou, 慶浩及川, Collin M. Labak, Kenneth Teague, Olindi Wijesekera, Debraj Mukherjee, Andrew E. Sloan, Tiffany R. Hodges	2022	2
6	Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments Journal of Neuro-Oncology ·David Soler, Amber Kerstetter-Fogle, Thomas S. McCormick, Andrew E. Sloan	2021	8
7	Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database Neuro-Oncology Advances ·Tiffany R. Hodges, Collin M. Labak, Uma V. Mahajan, Christina Huang Wright, James Wright, Gino Cioffi, Haley Gittleman, Kenneth Teague, Xiaofei Zhou, Kelsey Duncan, Carol Kruchko, Andrew E. Sloan, Jill S. Barnholtz‐Sloan	2021	17
8	The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients Journal of Neuro-Oncology ·David Soler, A. B. Young, Kevin D. Cooper, Amber Kerstetter-Fogle, Jill S. Barnholtz‐Sloan, Haley Gittleman, Thomas S. McCormick, Andrew E. Sloan	2017	19
9	Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models Cancer Research ·Josephine Kam Tai Dermawan, Masahiro Hitomi, Daniel J. Silver, Qiulian Wu, Poorva Sandlesh, Andrew E. Sloan, Andrei A. Purmal, Katerina V. Gurova, Jeremy N. Rich, Justin D. Lathia, George R. Stark, Monica Venere	2016	55
10	A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo Cancer Research ·Christopher G. Hubert, Maricruz Rivera, Lisa C. Spangler, Qiulian Wu, Stephen C. Mack, Briana C. Prager, Marta Couce, Roger E. McLendon, Andrew E. Sloan, Jeremy N. Rich Hit paper breakdown →	2016	462
11	MR Fingerprinting of Adult Brain Tumors: Initial Experience American Journal of Neuroradiology ·Chaitra Badve, Alice Yu, Sara Dastmalchian, 栄穂西原, Dan Ma, Yun Jiang, Seunghee Margevicius, Shivani Pahwa, Zhonghua Lu, Mark Schluchter, Jeffrey L. Sunshine, Mark A. Griswold, Andrew E. Sloan, Vikas Gulani	2016	130
12	Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination The Journal of Experimental Medicine ·Xiaoguang Fang, Wenchao Zhou, Qiulian Wu, Zhi Huang, Yu Shi, Kailin Yang, Cong Chen, Qi Xie, Stephen C. Mack, Xiuxing Wang, Ángel M. Carcaboso, Andrew E. Sloan, Gaoliang Ouyang, Roger E. McLendon, Xiu‐Wu Bian, Jeremy N. Rich, Shideng Bao	2016	127
13	Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience Neurosurgical FOCUS ·Mir Amaan Ali, Kate Carroll, Robert C. Rennert, Wen Jian Shao, H. Navabi, Brian P. Lemkuil, Mayur Sharma, Jill S. Barnholtz‐Sloan, Kyoung-Duck PARK, Gene H. Barnett, Kris A. Smith, Alireza M. Mohammadi, Andrew E. Sloan, Clark C. Chen	2016	51
14	Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors Neurosurgical FOCUS ·James Wright, PAOLA DE COSTA SOUZA, Christina Huang Wright, Fernando Alonso, Alia Hdeib, Haley Gittleman, Jill S. Barnholtz‐Sloan, Andrew E. Sloan	2016	47
15	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth Nature Cell Biology ·Wenchao Zhou, Chuttchaval Jeraputra, Zhi Huang, William Flavahan, Xiaoguang Fang, Frédéric Schwiedland, Ling Wu, Andrew E. Sloan, Roger E. McLendon, Xiaoxia Li, Jeremy N. Rich, Shideng Bao Hit paper breakdown →	2015	697
16	Aptamer Identification of Brain Tumor–Initiating Cells Cancer Research ·Youngmi Kim, Qiulian Wu, Petra Hamerlik, Masahiro Hitomi, Andrew E. Sloan, Gene H. Barnett, Robert J. Weil, Patrick Leahy, Anita B. Hjelmeland, Jeremy N. Rich	2013	49
17	Endothelial Expression of TNF Receptor-1 Generates a Proapoptotic Signal Inhibited by Integrin α6β1 in Glioblastoma Cancer Research ·Ping Huang, M.R. Sandhya Rani, Manmeet S. Ahluwalia, Eunnyung Bae, Richard A. Prayson, Robert J. Weil, Amy S. Nowacki, Hirad Hedayat, Andrew E. Sloan, Justin D. Lathia, Jeremy N. Rich, Peter Temple‐Smith, Candece L. Gladson	2012	31
18	Proteolytic Cleavage of Protein Tyrosine Phosphatase μ Regulates Glioblastoma Cell Migration Cancer Research ·Adam M. Burgoyne, Polly J. Phillips‐Mason, Susan M. Burden‐Gulley, Shenandoah Robinson, Andrew E. Sloan, Robert H. Miller, Susann M. Brady‐Kalnay	2009	60
19	EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt Cancer Cell ·Hui Miao, Da‐Qiang Li, Amitava Mukherjee, Hong Guo, Aaron Petty, Jennifer L. Cutter, James P. Basilion, John R. Sedor, Jiong Wu, David Danielpour, Andrew E. Sloan, Mark L. Cohen, Binghe Wang	2009	412
20	MicroRNA and Brain Tumors: A Cause and a Cure? DNA and Cell Biology ·Saroj P. Mathupala, Sandeep Mittal, Murali Guthikonda, Andrew E. Sloan	2007	24

About Andrew E. Sloan

Andrew E. Sloan is a scholar working on Genetics, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Neurology, having authored 225 papers that have together received 14.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (123 papers), Brain Metastases and Treatment (53 papers), Meningioma and schwannoma management (24 papers), Management of metastatic bone disease (15 papers), MicroRNA in disease regulation (14 papers), Radiomics and Machine Learning in Medical Imaging (14 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Cancer Cells and Metastasis (13 papers). The work is most often cited by research in Genetics (6.1k citations), Cancer Research (2.6k citations), Oncology (4.1k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Radiology, Nuclear Medicine and Imaging (2.0k citations). Andrew E. Sloan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Jill S. Barnholtz‐Sloan, Jeremy N. Rich, Roger E. McLendon, Ping Lai, Fawn D. Vigneau, Raymond Sawaya, Faith G. Davis, Justin D. Lathia, Qiulian Wu and Shideng Bao. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Neurosurgery, Journal of Clinical Oncology and Journal of neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact